Inventor
Lawrence R. McGee
Inventor
Pacifica, CA, US
Overview
Patents· 54 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
A61KPreparations for medical, dental or toiletry purposes14%
C07CAcyclic or carbocyclic compounds14%
C07BGeneral methods of organic chemistry8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07JSteroids3%
B05BSpraying apparatus2%
C07HSugars2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
11,124,537Inhibitors of glucocorticoid receptor202111,110,103Inhibitors of glucocorticoid receptor202110,836,789Inhibitors of glucocorticoid receptor202010,723,759Inhibitors of glucocorticoid receptor202010,472,387Inhibitors of glucocorticoid receptor201910,221,162Triazole agonists of the APJ receptor20199,873,701Heterocyclic compounds and their uses20189,868,721'Triazole agonists of the APJ receptor'20189,845,310Intermediates for preparing triazole agonists of the APJ receptor20179,801,867'Processes of making and crystalline forms of a MDM2 inhibitor'20179,751,864'Methods for preparing triazole agonists of the APJ receptor'20179,745,286'Triazole agonists of the APJ receptor'20179,656,998'Intermediates for preparing triazole agonists of the APJ receptor'20179,656,997'Triazole agonists of the APJ receptor'20179,623,018'Processes of making and crystalline forms of a MDM2 inhibitor'20179,593,129'Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer'20179,573,936'Triazole agonists of the APJ receptor'20179,359,355'Fused tricyclic dual inhibitors of CDK 4/6 and FLT3'20169,296,736'Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer'20168,980,903'Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors'20158,901,135'Heterocyclic compounds and their uses'20148,841,312'Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors'20148,623,885'Fused tricyclic dual inhibitors of CDK 4/6 and FLT3'20148,586,739'Heterocyclic compounds and their uses'20138,389,533'Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors'20138,193,199'Heterocyclic compounds and their uses'20128,003,665'Salts and polymorphs of a potent antidiabetic compound'20117,968,567'Compounds for the modulation of PPARγ activity'20117,960,408'Quinolinyl and benzothiazolyl modulators'20117,626,033'Compounds for the modulation of PPARγ activity'20097,601,841'Quinolinyl and benzothiazolyl modulators'20097,439,242'PPARγ modulators'20087,439,350'Nucleotide analogs'20087,223,761'Salts and polymorphs of a potent antidiabetic compound'20077,041,691'Compounds for the modulation of PPARγ activity'20066,770,648'Compounds for the modulation of PPAR activity'20046,620,827'PPAR modulators'20036,583,157'Quinolinyl and benzothiazolyl modulators'20036,518,438'Preparation of cyclohexene carboxylate derivatives'20036,225,460'Nucleotide analogs'20016,204,398'Preparation of cyclohexene carboxylate derivatives'20016,200,995'PPAR-.gamma. modulators'20016,057,459'Preparation of carbocyclic compounds'20006,034,118'Thiepane compounds'20005,886,213'Preparation of carbocyclic compounds'19995,859,284'Preparation of carbocyclic compounds'19995,811,450'Thiepane compounds'19985,705,524'Thiepane compounds'19985,674,863'Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor'19975,674,865'Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a'19975,663,166'Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor'19975,656,745'Nucleotide analogs'19975,565,449'Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor'19965,250,679'Nonpeptidyl platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub. receptor'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–1997Patents assigned to GENENTECH INC (5)· patent assignee history
1993–2021Based in Pacifica, CA, US· patent location history
1997–2008Patents assigned to GILEAD SCIENCES INC (11)· patent assignee history
2006–2019Patents assigned to AMGEN INC (29)· patent assignee history
2012–2014Patents assigned to MCGEE LAWRENCE R (6)· patent assignee history
2019–2021Patents assigned to ORIC PHARMACEUTICALS INC (5)· patent assignee history
2020Based in Pacific Palasades, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 29 | 2006–2019 |
| GILEAD SCIENCES INC | 11 | 1997–2008 |
| MCGEE LAWRENCE Rself | 6 | 2012–2014 |
| GENENTECH INC | 5 | 1993–1997 |
| ORIC PHARMACEUTICALS INC | 5 | 2019–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Pacifica, California, US | 53 | 1993–2021 |
| Pacific Palasades, California, US | 1 | 2020 |